Trends in detectable viral load by calendar year in the Australian HIV observational database
Authors:
- Matthew G LawMLMatthew G Law
- Ian WoolleyIWIan Woolley
- David J TempletonDTDavid J Templeton
- Norm RothNRNorm Roth
- John ChuahJCJohn Chuah
- Brian MulhallBMBrian Mulhall
- Peter CanavanPCPeter Canavan
- Hamish McManusHMHamish McManus
- David A CooperDCDavid A Cooper
- Kathy PetoumenosKPKathy Petoumenos
- The Australian Hiv Observational Database (Ahod)T(The Australian Hiv Observational Database (Ahod)
Open Access
- 1 January 2011
- journal article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 14 (1) , 10
Abstract
Background: Recent papers have suggested that expanded combination antiretroviral treatment (cART) through lower viral load may be a strategy to reduce HIV transmission at a population level. We assessed calendar trends in detectable viral load in patients recruited to the Australian HIV Observational Database who were receiving cART.Methods: Patients were included in analyses if they had started cART (defined as three or more antiretrovirals) and had at least one viral load assessment after 1 January 1997. We analyzed detectable viral load (>400 copies/ml) in the first and second six months of each calendar year while receiving cART. Repeated measures logistic regression methods were used to account for within and between patient variability. Rates of detectable viral load were predicted allowing for patients lost to follow up.Results: Analyses were based on 2439 patients and 31,339 viral load assessments between 1 January 1997 and 31 March 2009. Observed detectable viral load in patients receiving cART declined to 5.3% in the first half of 2009. Predicted detectable viral load based on multivariate models, allowing for patient loss to follow up, also declined over time, but at higher levels, to 13.8% in 2009.Conclusions: Predicted detectable viral load in Australian HIV Observational Database patients receiving cART declined over calendar time, albeit at higher levels than observed. However, over this period, HIV diagnoses and estimated HIV incidence increased in Australia.Keywords
Funding Information
- amfAR, The Foundation for AIDS Research
- Gilead Sciences
- Roche
- Pfizer
- GlaxoSmithKline
This publication has 17 references indexed in Scilit:
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyThe Lancet, 2010
- Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San FranciscoPLOS ONE, 2010
- Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatmentSexual Health, 2008
- Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infectionsSexual Health, 2008
- The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemicThe Lancet, 2006
- Rates of HIV‐1 Transmission per Coital Act, by Stage of HIV‐1 Infection, in Rakai, UgandaThe Journal of Infectious Diseases, 2005
- Modeling Trends in HIV Incidence Among Homosexual Men in Australia 1995???2006JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Modelling the effect of combination antiretroviral treatments on HIV incidenceAIDS, 2001
- Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, UgandaThe Lancet, 2001
- Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal TransmissionNew England Journal of Medicine, 1999